This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumar, D.
Right arrow Articles by Moore, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumar, D.
Right arrow Articles by Moore, J. J.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 108 No. 5 November 2001, pp. 1117-1122

Vitamin K Status of Premature Infants: Implications for Current Recommendations

Received Nov 29, 2000; accepted Apr 17, 2001.

Deepak Kumar*, Frank R. GreerDagger , Dennis M. Super*, John W. Suttie§, and John J. Moore*

From the * Department of Pediatrics, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio; and the Departments of Dagger  Pediatrics and Nutritional Sciences and § Biochemistry and Nutritional Sciences, University of Wisconsin, Madison, Wisconsin.

Objective.  Newborn infants are vitamin K deficient. Vitamin K status in full-term infants after intramuscular vitamin K supplementation at birth has been described. Similar information in growing premature infants has not been reported. The objective of this study was to assess vitamin K status in premature infants by measuring plasma vitamin K and plasma protein-induced in vitamin K absence (PIVKA II) from birth until 40 weeks' postconceptional age.

Methods.  Premature infants (<= 36 weeks' gestation) were divided at birth into groups by gestational age (group 1, <= 28 weeks; group 2, 29-32 weeks; group 3, 33-36 weeks). Supplemental vitamin K (1 mg intramuscularly) was administered at birth followed by 60 µg/day (weight <1000 g) or 130 µg/day (weight >= 1000 g) via total parenteral nutrition. After hyperalimentation, most received vitamin K-fortified enteral feedings with the remainder receiving unfortified breast milk. Blood was obtained for PIVKA II in cord blood and for PIVKA II and vitamin K at 2 weeks and 6 weeks after birth and at 40 weeks' postconception.

Results.  Of the 44 infants enrolled, 10 infants in each gestational age group completed the study. The patient characteristics for groups 1, 2, and 3 were as follows: gestational age, 26.3 ± 1.7, 30.3 ± 1.3, and 33.9 ± 1.1 weeks; birth weight, 876 ± 176, 1365 ± 186, and 1906 ± 163 g; and days of hyperalimentation, 28.9 ± 16, 16.8 ± 12, and 4.3 ± 4 days, respectively. At 2 weeks of age, the vitamin K intake and plasma levels were highest in group 1 versus group 3 (intake: 71.2 ± 39.6 vs 13.4 ± 16.3 µg/kg/day; plasma levels: 130.7 ± 125.6 vs 27.2 ± 24.4 ng/mL). By 40 weeks' postconception, the vitamin K intake and plasma levels were similar in all 3 groups (group 1, 2, and 3: intake, 11.4 ± 2.5, 15.4 ± 6.0, and 10.0 ± 7.0 µg/kg/day; plasma level, 5.4 ± 3.8, 5.9 ± 3.9, and 9.3 ± 8.5 ng/mL). None of the postnatal plasma samples had any detectable PIVKA II.

Conclusions.  Premature infants at 2 weeks of age have high plasma vitamin K levels compared with those at 40 weeks' postconceptional age secondary to the parenteral administration of large amounts of vitamin K. By 40 weeks' postconception, these values are similar to those in term formula-fed infants. Confirming "adequate vitamin K status," PIVKA II was undetectable by 2 weeks of life in all of the premature infants. With the potential for unforeseen consequences of high vitamin K levels, consideration should be given to reducing the amount of parenteral vitamin K supplementation in the first few weeks of life in premature infants.vitamin K, PIVKA II, premature, total parenteral nutrition, enteral nutrition. .


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 PediatricsHome page
P. Clarke, S. J. Mitchell, R. Wynn, S. Sundaram, V. Speed, E. Gardener, D. Roeves, and M. J. Shearer
Vitamin K Prophylaxis for Preterm Infants: A Randomized, Controlled Trial of 3 Regimens
Pediatrics, December 1, 2006; 118(6): e1657 - e1666.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
K Murayama, H Nagasaka, K Tate, Y Ohsone, M Kanazawa, K Kobayashi, Y Kohno, and M Takayanagi
Significant correlations between the flow volume of patent ductus venosus and early neonatal liver function: possible involvement of patent ductus venosus in postnatal liver function
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2006; 91(3): F175 - F179.
[Abstract] [Full Text] [PDF]

Home page
 Pediatr. Rev.Home page
U. Sethuraman
Vitamins
Pediatr. Rev., February 1, 2006; 27(2): 44 - 55.
[Full Text] [PDF]

Home page
 PediatricsHome page
D. T. Costakos, M. Porte, C. A. Miller, L. R. Blackmon, and On behalf of the Committee on Fetus and Newborn
Did "Controversies Concerning Vitamin K and the Newborn" Cover All the Controversies?
Pediatrics, May 1, 2004; 113(5): 1466 - 1467.
[Full Text] [PDF]